Supplementary Figure 8: Overlap between circRNAs significantly associated with ADAD versus Braak-score-adjusted AD and versus controls (CO).

ADAD versus AD* analysis was adjusted for neuropathological severity, measured by Braak score. All circRNAs were significantly associated at the false discovery rate threshold of 0.05. Sample sizes: ADADvsCO (nADAD = 17, ncontrol = 13); ADADvsAD* (samples with available Braak score: nADAD = 17, nAD = 73).